Tina Graungaard

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)

David Russell‐Jones, Bruce W. Bode, Christophe De Block et al. · Diabetes Care · 2017 · 176 citations · Full text

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis

Lars Hvilsted Rasmussen, Torben Bjerregaard Larsen, Tina Graungaard et al. · BMJ · 2012 · 122 citations · Full text

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

Chantal Mathieu, Bruce W. Bode, Edward Franek et al. · Diabetes Obesity and Metabolism · 2018 · 93 citations · Full text

A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

David C. Klonoff, Mark L. Evans, Wendy Lane et al. · Diabetes Obesity and Metabolism · 2018 · 76 citations · Full text

Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes

Eric Zijlstra, Marek Demissie, Tina Graungaard et al. · Journal of Diabetes Science and Technology · 2017 · 55 citations · Full text